|
The
patent as an economic weapon
Thomas
Schweiger, Greenpeace European Unit - April 1999
The idea of a patent is to protect
one's own economic interests. When Alexander Graham Bell invented
the telephone, he had to prevent others from stealing his
idea. By patenting it, he registered his claim to his invention
and gained control of any future use of it.
Arguably, this is a fair trade-off for someone who has invented
something and a possible incentive for others to invent something
even better for the benefit of society. But when it comes
to handing over control over our own genes or biodiversity
to individual companies, it becomes a totally different matter,
with potentially devastating effects for society. What may
be economically good for Monsanto and SmithKline Beecham may
not be good for society at all.
In the case of human genes being patented by pharmaceutical
companies, it will be entirely dependent on the economic rationale
of the company and the decisions of its executives whether
or not beneficial research and the development of new drugs
will ever take place. If the company decides it is not economically
feasible - e.g. because not enough people suffer from a certain
decease - then there is virtually nothing anyone can do about
it. Crucially, the patent holder can also prevent anyone else
from carrying out R&D or charge licence fees, thereby increasing
the costs of a possible drug. More than a decade of patenting
human genes in the USA has shown the devastating effects this
has had on the research and development of new therapies and
drugs. Patient organisations are vigorously fighting the system
(1).
In the area of farming and food production, the strategies
of the Life Science industry have been similar, in that they
have been trying to gain control over seeds. By doing so,
they can force farmers to buy new seeds every year, thereby
increasing their own profits at the cost of the farmers. They
can also prevent plant breeders from freely using existing
plant varieties to breed or develop new ones, which might
be even better than existing ones, thereby forcing competitors
out of the seed markets. It is no coincidence that chemical
companies like Monsanto are buying up numerous seed companies
all over the world. By controlling the seed market, they can
then easily introduce only their own genetically modified
seeds which are of little use to the farmer unless grown in
conjunction with chemical products such as herbicides from
the very same company. The farmers therefore become totally
dependent on the company and, by controlling the seeds - the
basics of our food chain - the companies can then exercise
control over the very food on our plates.
Genetic engineering is the spearhead of the chemical companies
entering and taking over our agrosystems - the patents are
the army to drive out any competitors.
References
1.
for further information have eg. a look at the homepages of
NORD or The
Council of Responsible Genetics
|